Sunday, October 25, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

GLP-1oral-semaglutidetype-2-diabetesadherenceautonomic-neuropathy

Low deep-breathing heart rate variability flags early oral semaglutide dropout

In 61 Japanese patients, CVR-R during deep breathing was 1.93% in those who quit within six months versus 3.26% in those who continued.

MH
By Maren Holt · Senior Reporter, GLP-1
Oct 23 20:00 ETSource: Journal of diabetes investigation

The wire

  1. 01A multicenter retrospective study in the Journal of Diabetes Investigation screened 203 patients starting oral semaglutide and analyzed 61; lower CVR-R during deep breathing was independently associated with discontinuation for nausea or vomiting (adjusted OR 0.191, AUC 0.832).
  2. 02A cutoff of 2.55% separated six-month persistence of 43.3% versus 87.1%, suggesting a bedside autonomic test could help flag patients likely to abandon oral semaglutide at initiation.
  3. 03The analysis is retrospective, single-country and small after exclusions, the cutoff was internally derived, and the difference versus resting CVR-R did not reach significance (DeLong P=0.085).

From the source

Parasympathetic dysfunction assessed by deep-breathing CVR-R is associated with early discontinuation of oral semaglutide in type 2 diabetes: A multicenter retrospective study

Journal of diabetes investigation · 2026 Oct 24 · Ogiso K, Deguchi T, Kawade S et al.

Read at pubmed.ncbi.nlm.nih.gov
PeptiPrescribed peptides from $99/moSee all →